TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive NCI Proposes New Grants and Centers For Molecular Target-Based Therapeutics March 26, 1999
TCL Archive The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation May 14, 2010